Purpose People with a history of melanoma commonly report a fear of cancer recurrence
(FCR), yet psychologic support is not routinely offered as part of ongoing melanoma care …

Objective To estimate the amount of fear of new or recurrent melanoma among people
treated for localised melanoma in an Australian specialist centre. Methods We randomly …

Immunotherapies and targeted therapies have revolutionised treatment of metastatic
melanoma and improved survival rates. However, survivors treated with novel therapies are …

Objective To systematically review psycho‐educational interventions developed for
melanoma survivors. Methods Electronic databases Medline, PsycINFO, Embase, and …

In this study we explored the psychosocial experiences of melanoma survivors at high risk of
developing new primary disease. A total of 20 survivors (9 men, 11 women, mean age 57.6 …

Purpose The results of a randomized, intervention study done in 1993 of psychoeducation
for patients with early-stage malignant melanoma showed a beneficial effect on recurrence …

BACKGROUND Melanoma accounts for> 79% of skin cancer‐related deaths, although it
accounts for only 4% of skin cancer incidence. Given the potential for lethality, it is likely that …

Objective To conduct a systematic review of the literature to identify the prevalence of, and
demonstrated risk factors for, psychological distress among individuals affected by, or at …

We aimed to determine the prevalence and importance of fear of cancer progression (FoP)
in melanoma patients with stage IA tumours to assess psychosocial and demographic …

Purpose Fear of cancer recurrence (FCR) is prevalent, distressing, and long lasting. This
study evaluated the impact of a theoretically/empirically based intervention (ConquerFear) …